NO881775L - Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter. - Google Patents

Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.

Info

Publication number
NO881775L
NO881775L NO881775A NO881775A NO881775L NO 881775 L NO881775 L NO 881775L NO 881775 A NO881775 A NO 881775A NO 881775 A NO881775 A NO 881775A NO 881775 L NO881775 L NO 881775L
Authority
NO
Norway
Prior art keywords
kinolinamines
heteroylkyl
medicines
condensed
compounds
Prior art date
Application number
NO881775A
Other languages
English (en)
Other versions
NO166324C (no
NO881775D0 (no
NO166324B (no
Inventor
Gregory Michael Shutske
Richard Charles Effland
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO881775D0 publication Critical patent/NO881775D0/no
Publication of NO881775L publication Critical patent/NO881775L/no
Publication of NO166324B publication Critical patent/NO166324B/no
Publication of NO166324C publication Critical patent/NO166324C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
NO881775A 1987-04-23 1988-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer. NO166324C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4156287A 1987-04-23 1987-04-23

Publications (4)

Publication Number Publication Date
NO881775D0 NO881775D0 (no) 1988-04-22
NO881775L true NO881775L (no) 1988-10-24
NO166324B NO166324B (no) 1991-03-25
NO166324C NO166324C (no) 1991-07-03

Family

ID=21917178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881775A NO166324C (no) 1987-04-23 1988-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer.

Country Status (18)

Country Link
EP (1) EP0287977B1 (no)
JP (1) JP2835050B2 (no)
KR (1) KR960006392B1 (no)
AR (1) AR246971A1 (no)
AT (1) ATE107930T1 (no)
AU (1) AU609122B2 (no)
CA (1) CA1322368C (no)
DE (1) DE3850436T2 (no)
DK (1) DK174628B1 (no)
ES (1) ES2056849T3 (no)
FI (1) FI89801C (no)
IE (1) IE64197B1 (no)
IL (1) IL86158A (no)
NO (1) NO166324C (no)
NZ (1) NZ224313A (no)
PH (1) PH24884A (no)
PT (1) PT87287B (no)
ZA (1) ZA882811B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
JP2720517B2 (ja) * 1989-05-31 1998-03-04 三菱化学株式会社 9―アシルアミノーテトラヒドロアクリジン誘導体および該誘導体を有効成分とする記憶障害改善剤
ES2042384B1 (es) * 1991-12-26 1994-06-01 Boehringer Ingelheim Espana Procedimiento para obtener derivados bis-piridinicos.
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674790A (en) * 1970-05-01 1972-07-04 American Home Prod 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants
ES431307A1 (es) * 1973-11-16 1976-09-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos derivados de quinoleina.
GB8610980D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
JPS63264485A (ja) * 1986-12-29 1988-11-01 Sumitomo Pharmaceut Co Ltd アミノキノリン誘導体

Also Published As

Publication number Publication date
DK222888D0 (da) 1988-04-22
IL86158A (en) 1994-08-26
DK222888A (da) 1988-10-24
PH24884A (en) 1990-12-26
FI881873A0 (fi) 1988-04-21
EP0287977A3 (en) 1989-09-06
FI89801B (fi) 1993-08-13
PT87287B (pt) 1992-08-31
KR880012606A (ko) 1988-11-28
PT87287A (pt) 1988-05-01
NO166324C (no) 1991-07-03
AU1509988A (en) 1988-10-27
IL86158A0 (en) 1988-11-15
KR960006392B1 (ko) 1996-05-15
AU609122B2 (en) 1991-04-26
ATE107930T1 (de) 1994-07-15
JP2835050B2 (ja) 1998-12-14
EP0287977B1 (en) 1994-06-29
DK174628B1 (da) 2003-07-28
JPS63284175A (ja) 1988-11-21
EP0287977A2 (en) 1988-10-26
NO881775D0 (no) 1988-04-22
AR246971A1 (es) 1994-10-31
DE3850436T2 (de) 1994-11-17
IE64197B1 (en) 1995-07-12
NO166324B (no) 1991-03-25
ES2056849T3 (es) 1994-10-16
FI89801C (fi) 1993-11-25
NZ224313A (en) 1991-01-29
ZA882811B (en) 1988-10-20
FI881873A (fi) 1988-10-24
IE881214L (en) 1988-10-23
DE3850436D1 (de) 1994-08-04
CA1322368C (en) 1993-09-21

Similar Documents

Publication Publication Date Title
NO870078D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse samt legemidler som inneholder de.
DK647087A (da) Substituerede basiske tetraliner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK675787D0 (da) 8-substituerede 2-aminotetraliner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO881164D0 (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
NO882075L (no) 9-alfa-hydroksysteroider, deres fremstilling, en fremgangsmaate for fremstilling av de tilsvarende 9(11)-dehydroderivater samt farmasoeytiske preparater inneholdende forbindelsene.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
DK613886A (da) 5-heterocyclyl-1-arylpyrazoler, deres fremstilling og anvendelse som skadedyrsbekaempelsesmidler samt fremstilling og mellemprodukter og disses anvendelse
DK539087D0 (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK656588A (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK303688D0 (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK55188D0 (da) Alkylsubstituerede n-benzopyranyllactamer, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
FI860014A (fi) Preparat med foerdroejd verkan, foerfarande foer deras framstaellning samt motsvarande preparat foer human- eller veterinaermedicinsk anvaendning.
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO881775L (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.
DK284688A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK401988D0 (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO882065D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne.
DK380887A (da) Bisucaberin, fremgangsmaade til dens fremstilling samt dens anvendelse som laegemiddel
DK11089A (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
DK225189D0 (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK519488A (da) Substituerede pyridiner, fremgangsmaader til fremstilling heraf, mellemprodukter, som er anvendelige ved deres fremstilling samt farmaceutiske midler indeholdende dem
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DK135288D0 (da) Thiazolylderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider